A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
nytimes.com
31.08.2026 11:03
55 views
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Related stories
Spurs Guard Dylan Harper Makes Bold Claim About Himself and Stephon Castle
newsweek.com · 13.10
Jalen Hurts, Nick Sirianni Disagree on Play Call in Eagles Loss vs Jaguars
newsweek.com · 13.10
Hall of Fame WR Expects Big Things From Marvin Harrison Jr. After Texans Trade
newsweek.com · 13.10
Seahawks' Jaxon Smith-Njigba on Injury Report Before 'TNF' Clash With Broncos
newsweek.com · 13.10
Lane Kiffin Takes Shot at Ole Miss With Blunt Tampering Question
newsweek.com · 13.10
Broncos Get Blunt Reality Check on Bo Nix After Win Over Chargers
newsweek.com · 13.10